New Key Statistics Module, Z-Score and F-Score
OTCPK:ISCO Key Ratios
| Market Cap $ M | 0.52 |
| Enterprise Value $ M | 3.17 |
| P/E(ttm) | -- |
| PE Ratio without NRI | -- |
| Forward PE Ratio | -- |
| Price/Book | -- |
| Price/Sales | 0.06 |
| Price/Free Cash Flow | 0.62 |
| Price/Owner Earnings | -- |
| Payout Ratio % | -- |
| Revenue (TTM) $ M | 7.00 |
| EPS (TTM) $ | -0.03 |
| Beneish M-Score | -4.25 |
| 10-y EBITDA Growth Rate % | -- |
| 5-y EBITDA Growth Rate % | -- |
| y-y EBITDA Growth Rate % | 733.30 |
| EV-to-EBIT | 395.63 |
| EV-to-EBITDA | 15.67 |
| PEG | -- |
| Shares Outstanding M | 8.00 |
| Net Margin (%) | -1.68 |
| Operating Margin % | -8.51 |
| Pre-tax Margin (%) | -1.68 |
| Quick Ratio | 0.47 |
| Current Ratio | 0.73 |
| ROA % (ttm) | -2.40 |
| ROE % (ttm) | -- |
| ROIC % (ttm) | -11.16 |
| Dividend Yield % | -- |
| Altman Z-Score | -27.50 |
ISCO Number of Guru Trades
ISCO Volume of Guru Trades
Gurus Latest Trades with OTCPK:ISCO
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
OTCPK:ISCO is held by these investors
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
International Stem Cell Corp Insider Transactions
No Available Data
News about OTCPK:ISCO
Total 0- 1
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers